Mount Sinai Launches Cardiac Catheterization Artificial Intelligence Research Lab
New AI research lab at The Mount Sinai Hospital aims to transform patient care for complex heart procedures
Dr. Annapoorna Kini (left) and her team outside of The Samuel Fineman Cardiac Catheterization Artificial Intelligence Research Lab
Mount Sinai Fuster Heart Hospital has announced the launch of The Samuel Fineman Cardiac Catheterization Artificial Intelligence (AI) Research Lab. This new lab will leverage the hospital’s world-renowned Cardiac Catheterization Lab and its unrivaled expertise to advance the field of interventional cardiology and enhance patient care, patient outcomes, as well as to optimize complex treatment decisions.
Annapoorna Kini, MD, will serve as Director of The Samuel Fineman Cardiac Catheterization Artificial Intelligence Research Lab. As Director of The Mount Sinai Hospital’s Cardiac Catheterization Lab, she leads an internationally acclaimed team renowned for its exceptional safety, outstanding patient outcomes, and expertise in treating complex cases.
“While AI is not a magic solution to every problem, there are many places it can make a notable improvement over traditional techniques or bring some approaches that were never possible within reach. In five or so years, we think that many workflows can be augmented by AI to better focus our resources where they are most needed,” says Dr. Kini.
“In our Cath Lab at Mount Sinai, we have always been at the forefront of using rapidly evolving AI technologies to advance patient care. We have already implemented AI applications to augment patient engagement and care coordination, and we are now moving to the next level by integrating AI technologies in our research and clinical work,” says Dr. Kini, who also serves as Director of The Mount Sinai Hospital’s Cardiac Catheterization Laboratory. “As an early adopter in adapting to a future with AI, we plan to continue to be a leader in embedding AI in our processes and work flows to achieve even better outcomes for our patients.”
Dr. Kini and her team will host the lab’s inaugural AI Symposium with The Fineman Cardiac Catheterization Artificial Intelligence Research Lab on Monday, September 15. The event will be held at The Mount Sinai Hospital from 4 to 6:15 pm.
Dr. Kini will lead all AI research efforts within The Samuel Fineman Cardiac Catheterization Artificial Intelligence Research Lab. The new lab will focus on many aspects of interventional cardiology, from procedural to educational. Through internal as well as external collaborations, new explorations into existing data expose insights that can make a significant impact on how health care is delivered. From risk stratification to case planning, optimizing outcomes, and more, artificial intelligence has the capability to spur whole new levels of innovation.
The Fineman Cardiac Catheterization Artificial Intelligence Research Lab honors the memory of Samuel Fineman, who passed away in 2021 and left a generous gift to Mount Sinai. This gift was made in appreciation of the exceptional cardiac care he received from Samin K. Sharma, MD, Director of the Mount Sinai Fuster Heart Hospital Cardiovascular Clinical Institute and former Director of The Mount Sinai Hospital’s Cardiac Catheterization Laboratory. The lab was dedicated this summer in his memory and in honor of Dr. Kini. Mr. Fineman’s generosity will be permanently recognized on a plaque outside of the Catheterization Lab, ensuring his gift to Mount Sinai is memorialized for years to come.
“I am particularly proud of the foresight and enthusiasm demonstrated by our team at the Mount Sinai Cardiac Catheterization Lab in adopting artificial intelligence technologies in our work,” says Dr. Sharma. “While we are proud to be recognized as a global leader in the quality and safety of the care we provide to our patients, I am confident that we will continue to leverage and apply the latest revolutions in AI technologies to drive the standards of our care and patient outcomes to even higher levels.”
Mount Sinai Is a World Leader in Cardiology and Heart Surgery
Mount Sinai Fuster Heart Hospital at The Mount Sinai Hospital ranks No. 2 nationally for cardiology, heart, and vascular surgery, according to U.S. News & World Report®. It also ranks No. 1 in New York and No. 6 globally according to Newsweek’s “The World’s Best Specialized Hospitals.”
It is part of Mount Sinai Health System, which is New York City's largest academic medical system, encompassing seven hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. We advance medicine and health through unrivaled education and translational research and discovery to deliver care that is the safest, highest-quality, most accessible and equitable, and the best value of any health system in the nation. The Health System includes approximately 9,000 primary and specialty care physicians; 10 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 48 multidisciplinary research, educational, and clinical institutes. Hospitals within the Health System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report's® “Best Hospitals” Honor Roll for 2025-2026.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Instagram, LinkedIn, X, and YouTube.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across seven hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 9,000 primary and specialty care physicians and 10 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report® “Best Hospitals” Honor Roll for 2025-2026.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Instagram, LinkedIn, X, and YouTube.